| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.7% | -21% | $108,913,159 | -$28,532,250 | 16,111,414 | -21% | T. Rowe Price Investment Management, Inc. | 31 Dec 2025 |
| Paradigm Biocapital Advisors LP | 5.3% | $56,391,833 | 15,159,095 | Paradigm BioCapital Advisors LP | 07 Jan 2026 | |||
| Frazier Life Sciences Public Fund, L.P. | 5.3% | -34% | $21,355,029 | -$10,702,679 | 15,038,753 | -33% | Frazier Life Sciences Public Fund, L.P. | 30 Jun 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5.1% | +18% | $20,592,846 | +$3,105,540 | 14,502,004 | +18% | Suvretta Capital Management, LLC | 30 Jun 2025 |
| Logos Global Management LP | 4.8% | -10% | $29,648,000 | -$3,270,000 | 13,600,000 | -9.9% | Logos Global Management LP | 30 Sep 2025 |
| NOVARTIS PHARMA AG | 4.4% | $17,107,692 | 12,307,692 | Novartis Pharma AG | 31 Dec 2024 |
As of 31 Dec 2025, 152 institutional investors reported holding 219,275,540 shares of Erasca, Inc. - COMMON STOCK (ERAS). This represents 78% of the company’s total 282,656,386 outstanding shares.
The largest institutional shareholders of Erasca, Inc. - COMMON STOCK (ERAS) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8% | 22,729,436 | 0% | 2.3% | $84,553,502 |
| VR ADVISER, LLC | 6.3% | 17,857,083 | 0% | 3.3% | $66,428,349 |
| T. Rowe Price Investment Management, Inc. | 5.7% | 16,111,414 | -20% | 0.04% | $59,935,000 |
| BlackRock, Inc. | 5.5% | 15,597,330 | +3.5% | 0% | $58,022,066 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5.1% | 14,502,004 | 0% | 1.3% | $53,947,455 |
| Paradigm Biocapital Advisors LP | 5% | 14,159,095 | +4.4% | 1.4% | $52,671,833 |
| Logos Global Management LP | 4.6% | 13,000,000 | -14% | 3.2% | $48,360,000 |
| VANGUARD GROUP INC | 4.5% | 12,812,156 | +0% | 0% | $47,661,220 |
| ARCH Venture Management, LLC | 3.9% | 11,055,554 | 0% | 6.3% | $41,126,661 |
| Vivo Capital, LLC | 3.3% | 9,273,428 | 0% | 2.2% | $34,497,152 |
| Siren, L.L.C. | 3.1% | 8,757,249 | 0% | 0.97% | $32,576,966 |
| STATE STREET CORP | 2.2% | 6,174,642 | +53% | 0% | $22,969,668 |
| 5AM Venture Management, LLC | 1.9% | 5,405,404 | 0% | 6.3% | $20,108,103 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 4,926,335 | +1.6% | 0% | $18,330,444 |
| Affinity Asset Advisors, LLC | 1.4% | 3,900,000 | -9% | 1% | $14,508,000 |
| Spruce Street Capital LP | 1.4% | 3,889,632 | 0% | 4.8% | $14,469,431 |
| GOLDMAN SACHS GROUP INC | 1.2% | 3,331,418 | +32% | 0% | $12,392,875 |
| a16z Capital Management, L.L.C. | 1% | 2,862,500 | 0% | 0.67% | $10,648,500 |
| MILLENNIUM MANAGEMENT LLC | 0.79% | 2,237,951 | -23% | 0.01% | $8,325,178 |
| Soleus Capital Management, L.P. | 0.76% | 2,162,162 | 0% | 0.34% | $8,043,243 |
| Woodline Partners LP | 0.68% | 1,930,642 | +26% | 0.03% | $7,181,988 |
| DIMENSIONAL FUND ADVISORS LP | 0.63% | 1,775,685 | +29% | 0% | $6,602,155 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.59% | 1,673,404 | -3% | 0% | $6,225,063 |
| BANK OF AMERICA CORP /DE/ | 0.57% | 1,611,850 | +5.1% | 0% | $5,996,083 |
| ExodusPoint Capital Management, LP | 0.53% | 1,490,967 | 0.06% | $5,546,397 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 219,275,540 | $815,700,968 | +$4,978,559 | $3.72 | 152 |
| 2025 Q3 | 214,973,158 | $468,651,223 | -$3,518,210 | $2.18 | 139 |
| 2025 Q2 | 218,177,770 | $277,145,224 | -$8,196,772 | $1.27 | 141 |
| 2025 Q1 | 224,275,876 | $307,274,963 | -$9,730,312 | $1.37 | 151 |
| 2024 Q4 | 230,866,824 | $579,481,287 | -$3,886,798 | $2.51 | 144 |
| 2024 Q3 | 232,039,374 | $633,439,326 | +$46,910,487 | $2.73 | 130 |
| 2024 Q2 | 203,567,396 | $480,459,612 | +$311,839,926 | $2.36 | 124 |
| 2024 Q1 | 72,681,232 | $149,721,765 | +$6,866,672 | $2.06 | 105 |
| 2023 Q4 | 69,247,665 | $147,523,921 | -$3,989,593 | $2.13 | 115 |
| 2023 Q3 | 71,279,487 | $140,403,646 | -$6,391,863 | $1.97 | 106 |
| 2023 Q2 | 74,333,071 | $205,158,369 | -$10,901,012 | $2.76 | 110 |
| 2023 Q1 | 78,047,305 | $234,907,735 | -$11,497,274 | $3.01 | 115 |
| 2022 Q4 | 79,824,946 | $344,037,900 | +$2,800,974 | $4.31 | 106 |
| 2022 Q3 | 80,523,466 | $628,084,382 | +$33,781,376 | $7.80 | 87 |
| 2022 Q2 | 76,887,302 | $428,260,749 | +$21,982,237 | $5.57 | 87 |
| 2022 Q1 | 72,825,959 | $626,627,487 | +$45,427,981 | $8.60 | 80 |
| 2021 Q4 | 63,677,801 | $987,988,866 | +$64,674,674 | $15.58 | 63 |
| 2021 Q3 | 44,137,190 | $918,521,616 | +$918,521,616 | $21.22 | 53 |